Back to Results

Physician Selected Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma

Primary Objective

To evaluate the overall response rate achieved with physician?s choice selinexor-based combination therapy

Study category: Cancer

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Location

University of Colorado Hospital

Principal Investigator
Peter Forsberg,  MD

Peter Forsberg, MD

Study ID

Protocol Number: 20-2202

More information available at ClinicalTrials.gov: NCT04925193

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers